GlassScriptPhysician profile
Kimberly Shepherd
NPI 1912095084
$1,319.68
in general payments reported to CMS, 2019-2025
25 companies · $403 in 2025
The $403 reported for 2025 was more than what 75% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $68.91 · 2021: $12.69 · 2023: $255 · 2024: $308 · 2025: $403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $966.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $965.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $198.09 | 2019-2025 | Lo Loestrin Fe |
| Astellas Pharma US INC | $163.28 | 2023-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $145.69 | 2023-2025 | |
| Daiichi Sankyo INC. | $137.40 | 2019-2025 | Injectafer |
| Allergan, INC. | $73.98 | 2019-2020 | |
| Pfizer INC. | $70.13 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $62.69 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $55.35 | 2023-2024 | Myfembree |
| Amag Pharmaceuticals, INC. | $54.86 | 2019-2020 | |
| Gynesonics, INC. | $50.40 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Organon LLC | $37.81 | 2023-2024 | Nexplanon |
| Biogen, INC. | $35.51 | 2024 | Zurzuvae |
| Aspira Women'S Health INC | $29.54 | 2024 | Ova1 |
| Exeltis, USA INC. | $28.54 | 2019-2020 | |
| Coopersurgical, INC. | $26.27 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $26.12 | 2019-2024 | Gardasil 9, Gardasil |
| Alexion Pharmaceuticals, INC. | $19.98 | 2024 | Ultomiris |
| Lupin INC. | $19.29 | 2019 | |
| Hologic Sales and Service, LLC | $17.60 | 2023 | Coolseal Generator |
| Caldera Medical, INC | $13.82 | 2023 | Desara |
| Avion Pharmaceuticals | $13.76 | 2019 | |
| Optumhealth Care Solutions, LLC | $13.54 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Channel Medsystems, INC. | $13.34 | 2025 | |
| Minerva Surgical, INC | $12.69 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Shepherd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.